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Self-rated health and risk of 
incident non-alcoholic fatty liver 
disease: A cohort study
Yoosoo chang  1,2,3,9, Jin-Won noh4,5,6,9, Joo Young cheon7, Yejin Kim2, Young Dae Kwon8 & 
Seungho Ryu1,2,3*
Although self-rated health (SRH), a subjective measure of overall health status, associates with 
metabolic abnormalities, studies on the relationship between SRH and non-alcoholic fatty liver disease 
(NAFLD), a hepatic manifestation of metabolic syndrome, are limited. In this study, we evaluated 
whether or not SRH predicts the risk of incident NAFLD. This cohort study was performed in a sample 
of 148,313 Korean adults free of ultrasound-diagnosed NAFLD at baseline with annual or biennial 
follow-up for a median of 3.7 years. SRH and NAFLD were measured at baseline and follow-up visits. 
NAFLD was determined based on the ultrasound-diagnosed fatty liver without excessive alcohol 
consumption or any other cause. Hazard ratios with 95% confidence intervals were estimated via a 
parametric proportional hazards model. During 522,696.1 person-years of follow-up, 23,855 individuals 
with new-onset NAFLD were identified (incidence rate, 45.6 per 1,000 person-years). After adjustments 
for possible confounders including total calorie intake, sleep duration, and depressive symptoms, the 
multivariate-adjusted hazard ratios (95% confidence intervals) for incident NAFLD comparing good, 
fair, and poor or very poor SRH to very good SRH were 1.06 (0.97–1.14), 1.18 (1.09–1.27), and 1.24 
(1.13–1.37), respectively. This association of SRH with incident NAFLD remained significant after 
accounting for changes in SRH and confounders during follow-up and was similar across clinically 
relevant subgroups. In a large-scale cohort study of apparently healthy Korean adults, poor SRH was 
independently and positively associated with incident NAFLD risk, indicating a predictive role of SRH as 
a health measure in NAFLD.
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease globally and encompasses the bland 
steatosis to nonalcoholic steatohepatitis (NASH) that has potential to develop into progressive liver disease 
including cirrhosis, hepatic failure, or liver cancer1,2. In addition to liver-related adverse outcomes3, NAFLD 
is also associated with metabolic abnormalities, renal disorders and cerebrovascular or cardiovascular disease 
(CVD)4–6 and is considered a hepatic manifestation of metabolic syndrome (MetS) as well as a multisystem 
disease7–9. Given the increasing burden of NAFLD and its liver and extrahepatic complications, it is crucial to 
develop preventive measures for targeting individuals at risk for NAFLD.
Self-rated health (SRH) is a reliable indicator to assess personal perceptions of subjective overall health status 
by a single question and is widely used in various health research fields10. Indeed, SRH has been reported to be 
independently predictive of various adverse health outcomes such as CVD, cerebrovascular disease, respiratory 
disease, functional deterioration, depressive symptoms, and all-cause mortality11. SRH is likely to capture the net 
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effects of various measured and unmeasured risk factors12. Previous studies demonstrated relationships of poor 
SRH with unhealthy lifestyle13–15 and metabolic derangements such as obesity, diabetes, MetS, and metabolically 
unhealthy status, all of which are closely related to insulin resistance and are also risk factors of NAFLD16–18. 
Additionally, poor SRH has been associated with elevated inflammatory markers and insulin resistance, impor-
tant key factors for NAFLD19,20. Until now, there are few studies to evaluate whether or not SRH predicts NAFLD.
Thus, we investigated the longitudinal relationship between SRH and new-onset NAFLD in a large cohort of 
apparently healthy Korean adults who underwent a health check-up examination with repeated measurements of 
SRH, NAFLD and other confounders including lifestyle habits, comorbidities, and metabolic parameters.
Materials and Methods
Study population. The present study is part of the Kangbuk Samsung Health Study, a cohort study of Korean 
men and women aged 18 years or older who annually or biannually underwent comprehensive health examina-
tions at the Kangbuk Samsung Hospital Health Screening Centers in Seoul or Suwon, Republic of Korea21. Most 
participants were employees of companies and local governmental organizations and their spouses. In Korea, 
annual or biennial health screening exams of the employees are required by the Industrial Safety and Health Law. 
The rest of the examinees voluntarily underwent self-paid health checkups.
This study involved examinees who underwent comprehensive examination from 2011 to 2016 and who par-
ticipated in at least one follow-up examination until the end of 2017 (n = 276,244). Participants were excluded 
for the following reasons at baseline: missing information on SRH or abdominal ultrasonography (n = 11,232); 
history of cancer (n = 6,245); type 2 diabetes (n = 10,170); fatty liver on ultrasound (n = 78,262); significant alco-
hol consumption (defined as alcohol intake ≥30 g/day for men and ≥20 g/day for women) (n = 41,885)2; positive 
serologic markers for hepatitis B or C virus (n = 9,533); use of steatogenic medications within the past year such 
as valproate, amiodarone, methotrexate, tamoxifen, or corticosteroids (n = 1,885)2; history of liver cirrhosis or 
ultrasound-diagnosed liver cirrhosis, or any type of liver disease (n = 27,604). Some individuals met more than 
one exclusion criterion, yielding a final analytic sample of 148,313 (Fig. 1).
The study was approved by the Institutional Review Board of Kangbuk Samsung Hospital, which waived the 
requirement for informed consent as we used only de-identified data routinely collected as part of a health screen-
ing program.
Measurements. Abdominal ultrasonography, blood tests and physical parameters were routinely measured 
as part of the basic health check-up program at baseline and follow-up visits. Data on demographic factors, soci-
oeconomic status, health behaviors, medical history and medication use were collected by standardized, struc-
tured, self-administered questionnaires22. Health behaviors and socioeconomic status were categorized as follows: 
smoking status (never, former, or current smoker), alcohol consumption (≤10 g/day and >10 g/day), physical 
activity (inactive, minimally active and health-enhancing physical activity (HEPA)), sleep duration (≤5, 6, 7, 8, 
or ≥9 hour), monthly household income (<6 million Korean won (4907 USD) or ≥6 million Korean won), job 
status (full-time job or part-time job) and education attainment (less than college graduate or college graduate 
or more). HEPA was defined when either of two criteria were satisfied: (i) vigorous-intensity activity on ≥3 days 
per week accumulating ≥1,500 metabolic equivalent task (MET) min/week; or (ii) seven days of any combination 
of walking, moderate-intensity, or vigorous-intensity activities achieving at least 3,000 MET min/week23. Usual 
dietary intake was assessed via a 106-item, semi-quantitative, self-administered food frequency questionnaire for 
Korean24. Depressive symptoms were assessed using the Korean version25 of the Center for Epidemiologic Studies 
Depression (CES-D) Scale26 and were categorized as CES-D score <16, 16–24, and ≥25.
Figure 1. Selection of the study population.
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SRH was assessed using a self-administered questionnaire in Korean at baseline and follow-up visits and was 
defined by responses to a single question such as “In general, how would you rate your health?”, with the possible 
choices of “very good” (1), “good” (2), “fair” (3), “poor” (4) or “very poor” (5)27,28. There have been a number of 
studies investigating the content validity of SRH across different ethnicities and populations27,29.
Anthropometric parameters were measured by trained nurses. Obesity was defined as body mass index (BMI) 
≥25 kg/m2 according to criteria for obesity in Asians30. Blood pressures (BP) were measured using an automated 
oscillometric device (53000, Welch Allyn, NY, USA) by trained nurses while examinees were sitting with the arm 
supported at heart level. Hypertension was defined as BP ≥140/90 mmHg or current use of BP-lowering agents. 
Type 2 diabetes mellitus was defined as fasting serum glucose ≥126 mg/dL, hemoglobin A1c (HbA1c) ≥6.5%, or 
current use of insulin or medications for diabetes.
Fasting blood measurements included glucose, HbA1c, alanine aminotransferase (ALT), insulin, high sen-
sitivity C-reactive protein (hsCRP), and lipid profiles including total cholesterol, low-density lipoprotein cho-
lesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. The homeostatic model 
assessment – insulin resistance (HOMA-IR) was calculated as follows: fasting blood insulin (uU/ml) × fasting 
blood glucose (mg/dL)/405.
Fatty liver was assessed based on abdominal ultrasound by experienced radiologists who were not aware 
of the study purpose with participants in the supine position with the right arm raised above the head.31 
Ultrasonographic diagnosis of fatty liver was based on standard criteria, including diffuse increase of fine echoes 
in the liver parenchyma compared with the kidney or spleen parenchyma, deep beam attenuation, and bright 
vessel walls.32 The inter- and intra-observer reliability for diagnosis of fatty liver was very high (kappa statistics 
of 0.74 and 0.94, respectively)33. Since we had excluded participants with significant alcohol consumption and 
other causes of hepatic steatosis at baseline (see further details in the exclusion criteria), incident cases of fatty 
liver were considered NAFLD.
Statistical analyses. SRH was categorized into four groups: (1) very good, (2) good, (3) fair, or 4) poor or 
very poor. Only a small proportion of participants responded very poor health, which was combined into the 
poor category. Characteristics of the study participants were presented by SRH. The development of NAFLD 
was the primary outcome. The incidence rate was expressed as the number of new-onset NAFLD cases per 1000 
person-years. Since we knew that NAFLD had occurred at some point between the two visits but did not know 
the precise timing of NAFLD development, we used a parametric proportional hazards model to account for this 
type of interval censoring (stpm command in Stata)34.
The adjusted hazard ratio (aHR) and 95% confidence interval (CI) for incident NAFLD were estimated using a 
parametric proportional hazards model. Models were initially adjusted for age and sex and then further adjusted 
for year of screening examination, center, education attainment, monthly household income, employment status, 
smoking status, alcohol consumption, physical activity, sleep duration, CES-D, total calorie intake, BMI, history 
of CVD, and history of hypertension (multivariable-adjusted model). To incorporate the change of SRH and con-
founders during follow-up, we performed time-dependent analyses while introducing SRH and other covariates 
as a time-varying covariate in the models. We assessed the proportional hazards assumption by examining graphs 
of estimated log (−log) survival; no violation of the assumption was found.
In addition, we performed subgroup analyses by age (<50 vs. ≥50 years), sex (men vs. women), current smok-
ing (yes vs. no), alcohol consumption (<10 vs. ≥10 g/day), HEPA (no vs. yes), and BMI (<25 vs. ≥25 kg/m2). 
Likelihood ratio tests comparing models with and without multiplicative interaction terms were used to eval-
uate interactions by subgroup characteristics. Statistical analyses were performed using STATA version 15.0 
(StataCorp LP, College Station, TX, USA). All p-values were two-tailed, and p-values < 0.05 were considered 
statistically significant.
Results
The average (SD) age of participants was 38.3 (7.7) years (Table 1). Age, male sex, high education attainment, 
high monthly household income, and alcohol consumption were positively associated with better SRH category, 
whereas part-time job (vs. full-time job), hypertension, a history of CVD, depressive symptoms based on CES-D, 
insulin resistance estimated by HOMA-IR, and systemic inflammation measured by hsCRP were associated with 
poorer SRH category.
During a median follow-up period of 3.7 years (interquartile range, 2.0–4.9 years; 522,696.1 person-years 
of follow-up), 23,855 new cases of NAFLD were identified, with a corresponding incidence rate of 45.6 per 
1,000 person-years. Poorer SRH was associated with a higher risk of developing NAFLD (Table 2). The age- 
and sex-adjusted HRs (95% CIs) for incident NAFLD comparing the good, fair, and poor or very poor vs. the 
very good SRH categories were 1.03 (0.96–1.11), 1.13 (1.05–1.21), and 1.27 (1.17–1.38), respectively (P for trend 
<0.001). After further adjustments for possible confounders including socioeconomic status (monthly house-
hold income, job status, education attainment), health behaviors, sleep duration, and depressive symptoms, the 
multivariable-adjusted hazard ratios (95% CIs) for NAFLD in good, fair, and poor or very poor SRH categories 
were 1.06 (0.97–1.14), 1.18 (1.09–1.27), and 1.24 (1.13–1.37), respectively, compared with the very good SRH cat-
egory (multivariable-adjusted model). Further adjustment for either HOMA-IR, hsCRP, or lipid profiles includ-
ing LDL-C, HDL-C, and triglycerides slightly attenuated the association between SRH and incident NAFLD but 
did not eliminate it (data not shown). When updated status in SRH and confounders over follow-up were treated 
as time-varying covariates, SRH independently associated with incident NAFLD in time-dependent models.
Association between SRH and incident NAFLD was similar across various subgroups without significant 
interactions by age (<50 vs. ≥50 years), sex (women vs. men), current smoking (no vs. yes), HEPA (no vs. yes), 
or obesity (no vs. yes) (Table 3 and Supplementary Table 1).
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Discussion
In this cohort study of 148,313 Korean adults free of ultrasound-diagnosed NAFLD at baseline, lower SRH 
was associated with an increased risk of developing NAFLD in a dose-dependent manner. This association was 
independent of potential confounders, including employment status, education attainment, household income, 
depressive symptoms, comorbidities, and lifestyle factors and was consistently observed when updated status of 
SRH and confounders at follow-up visits were incorporated as time-varying covariates. Therefore, the findings of 
the present study support an independent and predictive role of SRH as a health measure in the development of 
NAFLD. SRH may help identify people who have a high risk of future NAFLD.
Some studies exploring the relationship between SRH and NAFLD have shown conflicting results35. In 
a cross-sectional study of a nationally representative population in the United States, assessment of SRH was 
included as a subscale of health-related quality of life through the question, “Rate your health status as poor, fair, 
good, very good or excellent”35. In that study, NAFLD was associated with poorer SRH35. However, SRH was 





comparisonVery good (a) Good (b) Fair (c)
Poor or very 
poor (d)
Number 148,313 4,918 46,617 86,617 10,091
Age (years)a 37.4 (7.5) 38.1 (8.5) 37.4 (7.6) 37.4 (7.4) 36.9 (7.7) <0.001 a≠b, a≠c, a≠d, b≠d, c≠d
Male (%) 38.9 53.3 46.4 35.2 29.3 <0.001 a≠b≠c≠d
Current smoker (%) 18.5 18.6 19.4 18.1 18.1 <0.001 b≠c, b≠d
Alcohol intake (%)b 25.6 29.1 28.2 24.6 21.3 <0.001 a≠c, a≠d, b≠c, b≠d, c≠d
HEPA (%) 15.4 31.0 19.9 12.7 10.2 <0.001 a≠b≠c≠d
High education level (%)c 84.3 85.8 86.5 83.5 80.6 <0.001 a≠c, a≠d, b≠c, b≠d, c≠d
High income (%)d 32.4 36.7 34.6 31.3 29.2 <0.001 a≠b≠c≠d
Part time job (%) 7.6 6.1 6.7 8.2 8.3 <0.001 a≠c, a≠d, b≠c, b≠d
History of CVD (%) 0.6 0.5 0.5 0.7 1.2 <0.001 a≠d, b≠c, b≠d, c≠d
Hypertension (%) 5.1 4.6 4.60 5.2 6.1 <0.001 a≠d, b≠c, b≠d, c≠d
Sleep duration (hours) 7.0 (6.0–7.0) 7.0 (6.0–7.0) 7.0 (6.0–7.0) 7.0 (6.0–7.0) 6.0 (6.0–7.0) <0.001 a≠d, b≠d, c≠d, b≠c
CES–D ≥16 (%) 11.9 3.6 6.0 13.1 33.1 <0.001 a≠b≠c≠d
Obesity (%) 11.8 13.9 12.2 11.4 12.0 <0.001 a≠b, a≠c, a≠d, b≠c
BMI (kg/m2) 21.9 (2.6) 22.4 (2.4) 22.1 (2.5) 21.7 (2.7) 21.6 (3.0) <0.001 a≠b≠c≠d
Systolic BP (mmHg)a 105.4 (12.0) 106.9 (12.0) 106.2 (12.0) 105.1 (12.1) 103.7 (11.7) <0.001 a≠b≠c≠d
Diastolic BP (mmHg)a 67.2 (9.0) 67.7 (8.9) 67.5 (8.9) 67.1 (9.0) 66.4 (8.7) <0.001 a≠c, a≠d, b≠c, b≠d, c≠d
Glucose (mg/dl)a 91.6 (7.8) 91.7 (8.0) 91.8 (7.9) 91.6 (7.8) 91.1 (7.8) <0.001 a≠d, b≠c, b≠d, b≠d
Total cholesterol (mg/dl)a 187.6 (31.6) 187.7 (30.9) 187.9 (31.2) 187.7 (31.8) 185.8 (32.2) <0.001 a≠d, b≠d, b≠d,
LDL-C (mg/dl)a 113.0 (29.2) 112.9 (28.7) 113.3 (28.8) 113.0 (29.4) 111.4 (29.5) <0.001 a≠d, b≠d, b≠d,
HDL-C (mg/dl)a 62.6 (14.6) 63.1 (14.9) 62.8 (14.6) 62.6 (14.6) 62.3 (14.4) 0.001 a≠d
Triglycerides (mg/dl)e 75 (57–103) 74 (56–101) 75 (57–102) 75 (57–103) 75 (57–102) 0.035 a≠c










a≠c, a≠d, b≠c, 
b≠d, c≠d
hsCRP (mg/l)e 0.3 (0.2–0.6) 0.3 (0.2–0.6) 0.3 (0.2–0.6) 0.3 (0.2–0.6) 0.3 (0.2–0.7) <0.001 a≠b, a≠c, a≠d, b≠c, b≠d

















<0.001 a≠c, a≠d, b≠c, b≠d,
Table 1. Baseline characteristics of study participants by self-rated health. Data are amean (standard deviation), 
emedian (interquartile range), or percentage. Abbreviations: ALT, alanine aminotransferase; BMI, body 
mass index; BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression; CVD, cardiovascular 
disease; HDL-C, high-density lipoprotein-cholesterol; HEPA, health-enhancing physical activity; HOMA-IR, 
homeostasis model assessment of insulin resistance; hsCRP, high sensitivity C-reactive protein; LDL-C, low-
density lipoprotein cholesterol. b≥ 10 g of ethanol per day c≥ college graduate dmonthly household income ≥6 
million Korean won. famong 175,345 participants with plausible estimated energy intake levels (within three 
standard deviations from the log-transformed mean energy intake).
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group) without adjusting for lifestyle factors, depression, or laboratory testing, which are considered important 
confounders36,37. Therefore, it is unclear whether or not that observed association between SRH and NAFLD is 
independent due to lack of adjustment of potential confounders and it is also limited by their temporal ambiguity 
between SRH and NAFLD. Another study examined the relationship between NAFLD and self-reported general 
health perception in a sub-sample (213 participants) of the Israel national health and nutrition examination sur-
vey38. That study showed an inverse association between NAFLD and the prevalence of “very good” self-reported 
health perception, but this association was no longer observed after adjustment for BMI. Furthermore, in that 
study, the presence of NAFLD compared to the normal liver at the baseline survey did not predict perceptions 
of health deterioration after seven years of follow-up38. However, contrary to our study, that study focused on 
the impact of NAFLD on health perception while treating NAFLD as a predictive variable and SRH as a primary 
outcome. Before the present study, no cohort studies had examined the prospective association between SRH 
and new-onset of NAFLD. This is the first cohort study to show a positive and independent association between 
poorer SRH and incident NAFLD after adjusting for possible subjective and objective confounding factors such 
as demographic factors, lifestyle behaviors, depressive symptoms, comorbidities, insulin resistance, and systemic 
inflammation among 148,313 young and middle-aged adults without ultrasound-diagnosed NAFLD at baseline 
using a prospective cohort study design and repeated measurements including SRH, fatty liver status, and other 
covariates.
The mechanisms underlying the association between SRH and the development of NAFLD are not fully elu-
cidated yet. NAFLD is attributed to unhealthy health behaviors that are closely associated with excessive adipos-
ity, unfavorable lipid profiles and insulin resistance39–41. Furthermore, SRH has been reported to be associated 
with behavioral factors such as physical activity, smoking, dietary habit, alcohol drinking, and excessive adi-
posity, all of which are closely correlated with NAFLD13–15. SRH may comprehensively reflect lifestyle-related 
health conditions42. However, the relationship of poorer SRH with NAFLD risk, in our study, was observed even 
after adjustments for various lifestyle factors as well as depressive symptoms. Poor SRH has been reported to be 
associated with elevated inflammatory markers, another important key factor for NAFLD19,20. Thus, poor SRH 
might reflect the inflammatory milieu in favor of development of NAFLD and be related to symptoms related 
to systemic inflammation such as fatigue, malaise, sleepiness and reduced energy availability, which might pre-
vent individuals from engaging in physical activity or adopting healthy lifestyles and affect perceived physical 
functioning, one of the subscales of SRH43. However, in our study, further adjustment for lifestyle factors, hsCRP, 
and HOMA-IR did not fully attenuate the association between SRH and incident NAFLD. Even though SRH is 
easily assessed through a single-item question about “general health,” this question can be used to assess different 
dimensions of individual health status according to subjects’ own definition of health, which may include overall 
subjective and objective health at that point, possibly capturing an overall picture of individual’s health beyond 
the conventionally measured health conditions. Indeed, the pathogenesis of NAFLD is not clear and seems to be 
multifactorial with multiple proposed mechanisms44. Our study findings support SRH as a predictor of incident 
NAFLD independent of known NAFLD risk factors to help identify individuals at high risk for NAFLD, with the 
goal of implementing strategies to prevent incident NAFLD. However, further studies are required to determine 
what aspects of health experience can affect self-rated health, to determine whether sub-scales of SRH provide a 
sensitive marker of NAFLD risk, and to clarify whether the use of SRH as a part of actual consultation in clinical 
settings can improve patient health outcomes including NAFLD.
We note several limitations of the present study that are important to consider during the interpretation of 
the findings. First, we used ultrasonography to diagnose NAFLD without confirmation by liver biopsy, a gold 
standard for diagnosis of NAFLD. However, liver biopsy was neither feasible nor ethical in our large, low-risk 
individuals due to its invasive nature. Although abdominal ultrasound is widely used in population-based epi-
demiological studies with an acceptable diagnostic accuracy for diagnosing hepatic steatosis45, it cannot reliably 
detect fatty infiltration of the liver below the threshold of 20 to 33%46,47. Second, health behaviors were assessed 
based on self-administered questionnaires; thus, some degree of residual confounding might have been intro-













HR (95% CI)b in model using 
time-dependent variables
Very good 16,711.6 812 48.6 1.00 (reference) 1.00 (reference) 1.00 (reference)
Good 165,572.6 7,759 46.9 1.03 (0.96–1.11) 1.06 (0.97–1.14) 1.04 (0.96–1.12)
Fair 305,328.9 13,688 44.8 1.13 (1.05–1.21) 1.18 (1.09–1.27) 1.14 (1.05–1.23)
Poor or very poor 35,083.0 1,596 45.5 1.27 (1.17–1.38) 1.24 (1.13–1.37) 1.21 (1.10–1.33)
P for trend <0.001 <0.001 <0.001
Table 2. Development of nonalcoholic fatty liver disease according to self-rated health category. aEstimated 
from parametric proportional hazard models. Multivariable model was adjusted for age, center, year of 
screening exam, smoking status, alcohol intake, physical activity, education level, total calorie intake, body 
mass index, sleep duration, CES-D, monthly household income, part-time job, history of hypertension, and 
history of cardiovascular disease; model 2: model 1 plus adjustment for hsCRP and HOMA-IR. bEstimated from 
parametric proportional hazard models with self-rated health category, smoking status, alcohol intake, physical 
activity, BMI, total calorie intake, sleep duration, and CESD category as time-dependent variables and baseline 
age, sex, center, year of screening exam, education level, history of hypertension and history of CVD as time-
fixed variables. Abbreviations: CES-D, Center for Epidemiologic Studies Depression; CI, confidence interval; 
HR, hazard ratio.
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as subjective well-being in other population-based studies48–50. However, information on anxiety symptoms, 
in our study, was not available until 2017, limiting our ability to consider it in the analysis. Thus, we cannot 
exclude the possibility of residual confounding related to measurement errors and unmeasured confounders 
that might explain the observed association between SRH and incident NAFLD. Finally, our study population is 
much younger than those in previous studies on SRH: only 6.3% of the study population was 50 years old or older. 
Even though the interaction by age on the association between SRH and incident NAFLD was not statistically 
significant in our study, the association between SRH and incident NAFLD tended to be stronger in those 50 years 
or older (vs. younger group). Previous studies have shown that the role or meaning of SRH in predicting health 
outcomes might differ by age group51,52. Therefore, study findings derived from young and middle-aged Koreans 
who attended health-screening examinations might not be generalizable to other populations with different char-
acteristics such as age, race/ethnicity, or socioeconomic status. On the other hand, the relatively young age of our 
cohort participants may be a strength because our results have implications in young adults with poor SRH for 
future risk of NAFLD in relatively short-term follow-up and long-standing NAFLD since young adulthood, which 
might adversely health outcomes such as liver- and non-liver complications.
In conclusion, individuals with poorer SRH had a higher risk of new-onset NAFLD, indicating that SRH is useful 
as a predictive health measure for various adverse health outcomes including NAFLD. Health care providers should 
consider the predictive role of SRH in incident NAFLD among preventive strategies for NAFLD. Further prospective 
studies are warranted to better understand the mechanism by how SRH predicts incident NAFLD.
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